Regulation of mouse κ opioid receptor gene expression by retinoids

被引:31
作者
Bi, J [1 ]
Hu, XL [1 ]
Loh, HH [1 ]
Wei, LN [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
kappa opioid receptor; vitamin A; retinoic acid; transgenic mouse; gene expression; central nervous system;
D O I
10.1523/JNEUROSCI.21-05-01590.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of retinoids on the expression of kappa opioid receptor (KOR) gene was examined in normal and transgenic animals. KOR-lacZ transgene expression was specifically elevated in KOR-positive areas of the developing CNS by depleting vitamin A from animal diets. The endogenous KOR mRNA species, including all three isoforms, were also upregulated by depleting vitamin A in developing animals. Change in the expression of isoforms a and b is similar in prenatal stages but differs during postnatal development. Interestingly, upregulation of isoform c is most significant postnatally. The regulation of KOR gene by vitamin A was substantiated in a mouse embryonal carcinoma P19 culture system in which retinoic acid (RA), the most potent ingredient of vitamin A, was able to suppress the expression of all the three KOR isoforms and KOR protein. The RA-mediated suppression was blocked by an RA receptor antagonist and a histone deacetylase (HDAC) inhibitor. By using a reporter transfection assay in P19 cells, the potential genetic element responsible for RA-mediated suppression of KOR gene expression was located to intron 1 of the mouse KOR gene, which could also be blocked by HDAC inhibitor. Furthermore, suppression of KOR gene expression by RA in P19 cells appeared to be an indirect event and required protein synthesis. A role of RA in KOR gene regulation during developmental stages was discussed.
引用
收藏
页码:1590 / 1599
页数:10
相关论文
共 48 条
[1]   BETA-ENDORPHIN IS A POTENT INHIBITOR OF THYMIDINE INCORPORATION INTO DNA VIA MU-OPIOID AND KAPPA-OPIOID RECEPTORS IN FETAL-RAT BRAIN-CELL AGGREGATES IN CULTURE [J].
BARG, J ;
BELCHEVA, M ;
MCHALE, R ;
LEVY, R ;
VOGEL, Z ;
COSCIA, CJ .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :765-767
[2]  
Chang LM, 1997, J BIOL CHEM, V272, P10144
[3]   Expression of μ-, κ- and δ-opioid receptors in P19 mouse embryonal carcinoma cells [J].
Chen, HC ;
Wei, LN ;
Loh, HH .
NEUROSCIENCE, 1999, 92 (03) :1143-1155
[4]   Opioid receptors: Pinning down the opiate targets [J].
Childers, SR .
CURRENT BIOLOGY, 1997, 7 (11) :R695-R697
[5]   DISTRIBUTION OF NEUROPEPTIDE RECEPTORS - NEW VIEWS OF PEPTIDERGIC NEUROTRANSMISSION MADE POSSIBLE BY ANTIBODIES TO OPIOID RECEPTORS [J].
ELDE, R ;
ARVIDSSON, U ;
RIEDL, M ;
VULCHANOVA, L ;
LEE, JH ;
DADO, R ;
NAKANO, A ;
CHAKRABARTI, S ;
ZHANG, X ;
LOH, HH ;
LAW, PY ;
HOKFELT, T ;
WESSENDORF, M .
DIVERSITY OF INTERACTING RECEPTORS, 1995, 757 :390-404
[6]  
FRANKLIN KBJ, 1997, MOUSE BRAIN
[7]  
GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265
[8]   kappa-Opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: Relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids [J].
Gurwell, JA ;
Duncan, MJ ;
Maderspach, K ;
StieneMartin, A ;
Elde, RP ;
Hauser, KF .
BRAIN RESEARCH, 1996, 737 (1-2) :175-187
[9]   Promoter activity of mouse κ opioid receptor gene in transgenic mouse [J].
Hu, XL ;
Cao, S ;
Loh, HH ;
Wei, LN .
MOLECULAR BRAIN RESEARCH, 1999, 69 (01) :35-43
[10]  
KAUFMAN MH, 1992, ATLAS MOUSE DEV, P149